$3.25
0.46% today
Nasdaq, Dec 30, 09:17 pm CET
ISIN
US5560991094
Symbol
MGNX
Sector
Industry

MacroGenics, Inc. Target price 2024 - Analyst rating & recommendation

MacroGenics, Inc. Classifications & Recommendation:

Buy
36%
Hold
64%

MacroGenics, Inc. Price Target

Target Price $7.29
Price $3.23
Potential
Number of Estimates 7
7 Analysts have issued a price target MacroGenics, Inc. 2025 . The average MacroGenics, Inc. target price is $7.29. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 11 analysts: 4 Analysts recommend MacroGenics, Inc. to buy, 7 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the MacroGenics, Inc. stock has an average upside potential 2025 of . Most analysts recommend the MacroGenics, Inc. stock at Hold.

Sales and Margin forecast 2024, 2025 to 2028

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '23 2024
Estimates
Revenue Million $ 58.75 159.93
61.33% 172.22%
EBITDA Margin -269.96% -52.59%
274.42% 80.52%
Net Margin -16.02% -46.96%
80.11% 193.06%

9 Analysts have issued a sales forecast MacroGenics, Inc. 2024 . The average MacroGenics, Inc. sales estimate is

$160m
Unlock
. This is
13.16% higher
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
$189m 33.87%
Unlock
, the lowest is
$133m 5.89%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2023 $58.8m 61.33%
2024
$160m 172.22%
Unlock
2025
$78.0m 51.24%
Unlock
2026
$87.4m 12.06%
Unlock
2027
$76.4m 12.53%
Unlock
2028
$120m 57.14%
Unlock

1 Analyst has issued an EBITDA forecast MacroGenics, Inc. 2024 . The average MacroGenics, Inc. EBITDA estimate is

$-84.1m
Unlock
. This is
15.65% higher
Unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
$-84.1m 15.65%
Unlock
, the lowest is
$-84.1m 15.65%
Unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2023 $-159m 44.77%
2024
$-84.1m 46.97%
Unlock
2025
$-93.6m 11.31%
Unlock
2026
$-170m 81.31%
Unlock

EBITDA Margin

2023 -269.96% 274.42%
2024
-52.59% 80.52%
Unlock
2025
-120.06% 128.29%
Unlock
2026
-194.26% 61.80%
Unlock

10 MacroGenics, Inc. Analysts have issued a net profit forecast 2024. The average MacroGenics, Inc. net profit estimate is

$-75.1m
Unlock
. This is
23.77% higher
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
$0.0 100.00%
Unlock
, the lowest is
$-112m 14.01%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2023 $-9.4m 92.31%
2024
$-75.1m 697.85%
Unlock
2025
$-138m 83.92%
Unlock
2026
$-117m 15.01%
Unlock
2027
$-145m 23.61%
Unlock
2028
$-146m 0.47%
Unlock

Net Margin

2023 -16.02% 80.11%
2024
-46.96% 193.06%
Unlock
2025
-177.16% 277.26%
Unlock
2026
-134.38% 24.15%
Unlock
2027
-189.90% 41.32%
Unlock
2028
-121.42% 36.06%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2024, 2025 to 2028

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '23 2024
Estimates
Earnings Per Share $ -0.15 -1.20
92.31% 700.00%
P/E negative
EV/Sales 0.23

10 Analysts have issued a MacroGenics, Inc. forecast for earnings per share. The average MacroGenics, Inc. <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is

$-1.20
Unlock
. This is
23.57% higher
Unlock
than earnings per share in the financial year 2023. The highest <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS forecast is
$0.00 100.00%
Unlock
, the lowest is
$-1.79 14.01%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2023 $-0.15 92.31%
2024
$-1.20 700.00%
Unlock
2025
$-2.20 83.33%
Unlock
2026
$-1.87 15.00%
Unlock
2027
$-2.31 23.53%
Unlock
2028
$-2.32 0.43%
Unlock

P/E ratio

Current -2.06 116.65%
2024
-2.70 31.07%
Unlock
2025
-1.47 45.56%
Unlock
2026
-1.73 17.69%
Unlock
2027
-1.40 19.08%
Unlock
2028
-1.39 0.71%
Unlock

Based on analysts' sales estimates for 2024, the MacroGenics, Inc. stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of

and an <a href=https://blog.stocksguide.com/knowledge/price-sales-ratio-simply-explained>P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 0.26 91.93%
2024
0.23 12.31%
Unlock
2025
0.47 105.13%
Unlock
2026
0.42 10.75%
Unlock
2027
0.48 14.33%
Unlock
2028
0.30 36.36%
Unlock

P/S ratio

Current 1.43 71.62%
2024
1.27 11.63%
Unlock
2025
2.60 105.10%
Unlock
2026
2.32 10.76%
Unlock
2027
2.65 14.33%
Unlock
2028
1.69 36.36%
Unlock

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today